Myriad Genetics Nears Spin-off Date for Pharma Business

Myriad Genetics' shareholders of record on June 17 will receive on June 30 a pro-rata dividend of .25 share of Myriad Pharmaceuticals common stock for each share of Myriad Genetics held.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.